Non-Interventional F-Two Isoprostane Trial (NIFTI)

Traumatic Brain Injury Clinical Trial

— NIFTI  

Official title:

Non-Interventional F-Two Isoprostane Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00505908
• Other study ID #: 052007-034
• Status: Completed
• Start date: July 2007
• Est. completion date: December 2019

Study information

• Verified date: March 2020
• Source: University of Texas Southwestern Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Each year in the United States alone, 300,000 persons are hospitalized for traumatic brain injury, with approximately one quarter dying. Despite advances in aggressive neurosurgical interventions, intensive care monitoring and overall supportive management, many of those who do "survive" do not fully recover and are left with a varying degree of permanent disability. It is therefore imperative that new methods of early interventions be explored.

One possible road to effective therapy is to examine the timing of secondary injury via a biological marker, to help guide the timing of treatment directed specifically at early oxidant injury. A more thorough understanding of how quickly oxidant injury occurs will allow us to direct appropriate therapies targeted directly at oxidant injury within what is currently thought to be a very narrow window of opportunity for intervention, possibly peaking within the first two hours after the initial injury.

Potential participants include patients between the ages of 18 and 50 years who are admitted to Parkland Memorial Hospital with a diagnosis of severe traumatic brain injury. Blood, urine, and CSF (if patient requires a clinically indicated ventriculostomy) will be collected over the first 5 days post-injury. Clinically-relevant patient progress, clinically required interventions, neuro-imaging results, and demographics will be tracked while the patient is hospitalized, with final neurological outcome measured at 3 months.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: December 2019
• Est. primary completion date: December 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

1. Estimated age of 18 - 50 years

2. Glasgow Come Scale (GCS) score of between 3 and 8 prior to intubation and/or sedation.

3. Systolic blood pressure of >90 mm Hg

4. Receiving medical treatment in the Emergency Department (ED) of Parkland Hospital, a Level I Trauma Center in Dallas, Texas

Exclusion Criteria:

1. Those in whom the time of injury is unknown

2. Those with any 2 readings of systolic blood pressure of <90 prior to enrollment

3. Those who are known to have legal Do Not Resuscitate (DNR) orders in place prior to enrollment.

4. Those receiving CPR prior to enrollment

5. Known incarcerated individuals

6. Pulse ox reading of < 90 prior to enrollment

7. Status epilepticus prior to enrollment

8. Penetrating head trauma

Related Conditions & MeSH terms

• Brain Injuries
• Brain Injuries, Traumatic
• Traumatic Brain Injury

Locations

Country	Name	City	State
United States	Parkland Memorial Hospital	Dallas	Texas

Sponsors (1)

Lead Sponsor	Collaborator
University of Texas Southwestern Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Levels of oxidant injury in cerebrospinal fluid following severe traumatic brain injury	F2 Isoprostane levels in cerebrospinal fluid following severe traumatic brain injury	Up to 5 days